ProQR Announces the Grant of two Key Patents, protecting QR-010 for Cystic Fibrosis in the US and EU
Apr 03, 2017 11:02 am UTC| Business
Key Updates ProQR received notice of grant for 2 key patents protecting QR-010 for CF in the US and EU until at least July 2033QR-010 is currently being studied in 64 homozygous F508del patients in a Phase 1b safety,...
Apr 03, 2017 11:02 am UTC| Business
EWING, N.J., April 03, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that data from the 52-week pharmacokinetics and safety phase 3 study of subcutaneous testosterone enanthate delivered through the...
Apr 03, 2017 11:02 am UTC| Business
EWING, N.J., April 03, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that data from the 52-week pharmacokinetics and safety phase 3 study of subcutaneous testosterone enanthate delivered through the...
Apr 03, 2017 11:02 am UTC| Business
EWING, N.J., April 03, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that data from the 52-week pharmacokinetics and safety phase 3 study of subcutaneous testosterone enanthate delivered through the...
uniQure Announces Presentations at Upcoming April Conferences
Apr 03, 2017 11:02 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, April 03, 2017 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
uniQure Announces Presentations at Upcoming April Conferences
Apr 03, 2017 11:02 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, April 03, 2017 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
uniQure Announces Presentations at Upcoming April Conferences
Apr 03, 2017 11:02 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, April 03, 2017 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...